Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES may be associated with increased risk of late-stent thrombosis have many physicians putting the brakes on DES use. Despite this significant bump in the road, stent manufacturers are forging ahead with clinical trials on novel systems and on plans to roll out new DES platforms in 2008.
September 10, 2007 - Four analyses of three-year follow-up data that were presented at the ESC Congress 2007 showed that ...
According to the Centers for Disease Control and Prevention, more than 70 million Americans currently live with ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 7, 2007 - Gary Ansel, M.D., Riverside Methodist Hospital, successfully implanted the GORE VIABAHN ...
September 6, 2007 — ProSolv CardioVascular, a FUJIFILM company (ProSolv), announced at the 12th Annual Scientific ...
iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the debate over which stent designs and stenting techniques are most effective.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Combining all features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi Contrast Delivery System ...
Sony Electronics recently introduced its LMD-2450MD 24-inch monitor, which offers 10-bit signal processing and Sony ...
Possis Medical Inc. will feature the newest advancements in its “Complete Solution for Thrombus,” including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Siemens Automation and Drives (A&D) has added a 1MP color display to its portfolio of medical monitors. The SCD 19110 ...
September 6, 2007 – The New England Journal of Medicine published the first study to demonstrate a clear superiority of ...
Cordis Endovascular announced, at the 61st Annual Meeting of the Society for Vascular Surgery, the worldwide launch of ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Guerbet’s flagship X-ray contrast agent, Oxilan (ioxilan) injection, is a contrast agent that is a nonionic, low-viscous ...
September 6, 2007 - Cleveland Clinic will host its fifth annual Medical Innovation Summit, an international gathering of healthcare, business and media leaders to examine trends in medical innovation and cardiovascular technologies, Oct. 1-3.
September 6, 2007 - While few complications were found last year with implantable cardioverter defibrillators (ICDs), 15 ...